Financhill
Back

Altria Group Vs. Ultragenyx Pharmaceutical Industry Stock Comparison

Sell
42

MO
Altria Group

Last Price:
46.46
Seasonality Move:
2.4%
Sell
43

RARE
Ultragenyx Pharmaceutical

Last Price:
39.45
Seasonality Move:
3.65%
Sell
42
Altria Group (MO) is a Sell

Is Altria Group a Buy, Sell or Hold?

  • The current Altria Group [MO] share price is $45.74. The Score for MO is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
  • MO is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
43
Ultragenyx Pharmaceutical (RARE) is a Sell

Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical [RARE] share price is $39.60. The Score for RARE is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

MO Stock Price Chart

What is Altria Group's stock price today?

  • The Altria Group share price today is $45.74
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MO is experiencing slight buying pressure.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical's stock price today?

  • The Ultragenyx Pharmaceutical share price today is $39.60
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing buying pressure, which is a positive indicator for future bullish movement.

MO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.11 Buy
Relative Strength Index (14 RSI): 53.48 Buy
Chaikin Money Flow: 2376917 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (45.22 - 46.54) Sell
Bollinger Bands (100): (41.02 - 45.3) Buy

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.73 Sell
Relative Strength Index (14 RSI): 45.77 Sell
Chaikin Money Flow: 722527 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (38.99 - 42.29) Sell
Bollinger Bands (100): (41.03 - 48.83) Sell

MO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 45.38 Buy
20-day SMA: 45.82 Sell
50-day SMA: 44.55 Buy
200-day SMA: 42.39 Buy
8-day EMA: 45.46 Buy
20-day EMA: 45.56 Buy
50-day EMA: 44.8 Buy
200-day EMA: 43.36 Buy

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 40.38 Sell
20-day SMA: 40.41 Sell
50-day SMA: 41.94 Sell
200-day SMA: 42.46 Sell
8-day EMA: 39.76 Sell
20-day EMA: 40.54 Sell
50-day EMA: 42.03 Sell
200-day EMA: 43.46 Sell

Altria Group Earnings Growth & MO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.04 per share, an increase next quarter of $0.08 per share, an increase this year of $0.14 per share, and an increase next year of $0.20 per share.

Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.49 per share, an increase next quarter of $0.01 per share, an increase this year of $0.90 per share, and an increase next year of $1.07 per share.

Altria Group Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ultragenyx Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):